Americann Inc. (ACAN) 股价表现
查看Americann Inc.股价及公司表现,包括市值,涨跌幅,市盈率,以及历史及当前股价。
昨收 0.00
52周最高 0.08
今开 0.00
52周最低 0.00
振幅 0.00%
市盈率 0%
成交额
0.00
亿
市净率 0%
换手率 0.00%
总市值
0.00亿
股息 0
总股本
0.24
亿
股息收益率 0%
每手股数 1
Americann Inc.公司介绍
AmeriCann, Inc. develops, owns and supports advanced medical cannabis cultivation and processing facilities nationwide. The Company has a multi-market portfolio of over 1,000,000 square feet of sustainable cannabis production infrastructure in various stages of development.
AmeriCann's team includes experts in traditional horticulture, lean manufacturing, medical research, facility construction, regulatory compliance, security, marijuana cultivation and genetics, extraction processes, and infused product development.
To support local businesses that seek to serve cannabis patients in their communities we initiated the AmeriCann Preferred Partner Program. Through this program we provide an essential set of resources including advance cultivation facilities, access to a team of experts and in certain cases, capital for our partner's businesses. In addition, AmeriCann's team has been instrumental in winning cannabis licenses in competitive application processes throughout the country. This support is designed to assist our Preferred Partners in newly regulated markets.
AmeriCann leases facilities to our Preferred Partners that are designed with AmeriCann's propriety cultivation and processing system called "Cannopy." AmeriCann developed Cannopy with experts from traditional horticulture, lean manufacturing, regulatory compliance and cannabis cultivation. Cannopy includes automation throughout the production life-cycle, customized workflow processes, monitoring and controls, and top-line security systems. Cannopy empowers Preferred Partners to consistently produce medical marijuana for patients at the lowest cost in the most efficient, compliant manner. We provide initial and on-going training, policies, practices and procedures to operate the state-of-the-art facilities.
The expanding cannabis industry requires extensive real estate to meet the growing needs of patients. AmeriCann utilizes a proven strategy for identifying, acquiring and developing real estate specifically suited for cannabis operations. AmeriCann assists our Preferred Partners with the identification, design, permitting, acquisition, development and operation of scalable infrastructure to cultivate and to dispense medical marijuana in regulated markets.
As an early market participant, the Company plans to leverage its leadership in a formative industry to establish a dominant position as the cannabis industry expands.